Vaccination against ringworm can reduce the risk of developing dementia, a large new study. The results provide some of the strongest evidence yet that some viral infections can have an impact on brain function after years and prevent them can help prevent cognitive decline.
A study published in the Nature Journal found that the people who received the vaccine were 20% less likely to develop dementia in seven years, which were not vaccinated. Paul Harrison, a professor of psychiatry at the University of Oxford, said, “If you are reducing the risk of dementia by 20%, it is quite important in a public health context, given that we really do not have much at that time that slows down the onset of dementia,” said, Paul Harrison said, a professor of mental heopers at Oxford University. Harrison was not involved in the study, but he has done other researches that indicate the exposure to the vaccine of herpes.
Whether security can live beyond seven years, only can be determined with further research. But with some effective treatment or prevention currently, Harrison said, herpes vaccines “are some of the strongest potential protective effects against dementia …” appear.
Viruses are stams of ringworm that causes childhood chickenpox, varicella-joster, which usually remains dormant in nerve cells for decades. As people weakened age and their immune system, the virus can be activated again and can cause ringworm, such as symptoms such as burns, tingling, painful blisters and numbness. Nerve pain can be chronic and disable.
The study included an old form Shingles vaccine, ZostavaxWhich includes a modified version of the live virus. New vaccine, ShingrixWhich has a passive part of the virus, more effective and permanent, research show.
